Neuromodulation Market Size and Growth Analysis and Forecast To 2030

Neuromodulation Market is valued around USD 4.89 Billion in 2019 and expected to reach USD 20.08 Billion by 2030 with the CAGR of 13.7% over the forecast period.

Neuromodulation is a procedure which requires the implantation of electrodes directly to peripheral nerves or brain & pulse generator under skin. This helps to provide the electrical impulses which helps in the treatment of various neurological disorders such as epilepsy, pain management, tremor and many more. It provides long term effect on the disorders with no side effects as well as prevents the adverse effect.

Global Neuromodulation Market report is segmented on the basis of technology, biomaterial, application and regional. Based upon technology, the neuromodulation market is fragmented into internal neuromodulation and external neuromodulation. On the basis of biomaterial, the market is categorized into metallic, polymeric, and ceramic. Based on The regional bifurcation of countries includes North America, Europe, Asia-Pacific, and RoW which are further segmented into major countries such as U.S., UK, France, and others.

The neuromodulation market is mainly driven by the high prevalence of various neurological disorders followed by the presence of large geriatric population. There has been constant expansion of application in the treatment of various disorders followed by the growing demand for effective pain management therapies owing to growth in surgeries, trauma cases & many more. In addition, the major market players focused on the development of new & advanced products with constant approval led to the growth in product pipeline along with technological advancement in the market. On the other hand constant development of healthcare facilities along with the growth in healthcare expenditure followed by growing awareness among people is likely to anticipate the market growth. However, high cost of the Neurostimulators along with the lack of skilled professionals trained in neuromodulation therapy is likely to inhibit the market growth during forecast period.

Download sample copy of this report at https://www.nextmsc.com/Neuromodulation-Market/request-sample

The developed regions such as North America and Europe are expected to hold the major market share owing to the presence of major market players in the region along with technological advancement. Moreover, constant growth in FDA approvals along with growing investments in the market is likely to fuel the market growth. Asia Pacific is expected to dominate the neuromodulation market in terms of growth rate owing to the rising geriatric population as well as high prevalence rate of neurological disorders. In addition, growing awareness followed by the developing healthcare infrastructure supported by the high adoption rate of developed technology is most likely to enhance the market growth.

The major market players profiled in the neuromodulation market includes St. Jude Medical, Inc., LivaNova PLC, Medtronic plc, Boston Scientific Corporation, BioControl Medical, Bioness Inc., EnteroMedics Inc, NeuroPace Inc, Aleva Neurotherapeutics SA, and Nevro Corporation among others.

Neuromodulation is the physiological process by which a given neuron uses one or more chemicals to regulate diverse populations of neurons.

The key drivers for the growth of neuromodulation market include rise in geriatric population, their vulnerability for neurological disorders, increase in incidence of neurological diseases, such as Alzheimer’s and Parkinson’s diseases, and the increase in awareness regarding the safety and efficacy of neurostimulator devices. However, restrains, such as lack of trained healthcare professionals and stringent approval policies, are expected to hinder the market.

This report provides a complete quantitative data and qualitative analysis on the global market for Neuromodulation. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.

About Us:

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that range from the pre consultation to after-sales services provide an excellent client experience and ensure right strategic decision making for businesses.

Contact US:

Joseph Lawrence (Head - Client Engagement & Servicing)

[email protected]